Vandenput I[Author] - Search Results

Year	Number of Results
2005	1
2006	2
2007	1
2008	1
2009	5
2010	1
2011	7
2012	3
2013	2
2014	1
2015	1
2017	1
2018	1
2019	1
2022	0

1

Neoadjuvant chemotherapy followed by surgery for advanced-stage endometrial cancer.

de Lange NM, Ezendam NPM, Kwon JS, Vandenput I, Mirchandani D, Amant F, van der Putten LJM, Pijnenborg JMA. de Lange NM, et al. Among authors: vandenput i. Curr Oncol. 2019 Apr;26(2):e226-e232. doi: 10.3747/co.26.4655. Epub 2019 Apr 1. Curr Oncol. 2019. PMID: 31043831 Free PMC article.

2

Clinicopathologic study in uterine cancer.

Vandenput I. Vandenput I. Facts Views Vis Obgyn. 2011;3(3):189-202. Facts Views Vis Obgyn. 2011. PMID: 24753865 Free PMC article.

3

Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.

van der Horst PH, Wang Y, Vandenput I, Kühne LC, Ewing PC, van Ijcken WF, van der Zee M, Amant F, Burger CW, Blok LJ. van der Horst PH, et al. Among authors: vandenput i. PLoS One. 2012;7(1):e30840. doi: 10.1371/journal.pone.0030840. Epub 2012 Jan 25. PLoS One. 2012. PMID: 22295114 Free PMC article.

4

Synchronous ovarian and endometrial cancer--an international multicenter case-control study.

Heitz F, Amant F, Fotopoulou C, Battista MJ, Wimberger P, Traut A, Fisseler-Eckhoff A, Harter P, Vandenput I, Sehouli J, Schmidt M, Kimmig R, du Bois R, du Bois A. Heitz F, et al. Among authors: vandenput i. Int J Gynecol Cancer. 2014 Jan;24(1):54-60. doi: 10.1097/IGC.0000000000000019. Int J Gynecol Cancer. 2014. PMID: 24300466

5

Kit gene in endometrial carcinoma: an immunohistochemical and mutational analysis.

Vandenput I, Debiec-Rychter M, Capoen A, Verbist G, Vergote I, Moerman P, Amant F. Vandenput I, et al. Int J Gynecol Cancer. 2011 Feb;21(2):203-5. doi: 10.1097/IGC.0b013e3182055c94. Int J Gynecol Cancer. 2011. PMID: 21270602

6

Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial.

Van Lieshout LAM, Pijlman B, Vos MC, de Groot MJM, Houterman S, Coppus SFPJ, Harmsen MG, Vandenput I, Piek JMJ. Van Lieshout LAM, et al. Among authors: vandenput i. Maturitas. 2018 Jan;107:1-6. doi: 10.1016/j.maturitas.2017.09.012. Epub 2017 Oct 3. Maturitas. 2018. PMID: 29169572 Clinical Trial.

7

Evolution in endometrial cancer: evidence from an immunohistochemical study.

Vandenput I, Trovik J, Leunen K, Wik E, Stefansson I, Akslen L, Moerman P, Vergote I, Salvesen H, Amant F. Vandenput I, et al. Int J Gynecol Cancer. 2011 Feb;21(2):316-22. doi: 10.1097/IGC.0b013e31820575f5. Int J Gynecol Cancer. 2011. PMID: 21734474

8

The use of lymph vessel markers to predict endometrial cancer outcome.

Vandenput I, Vanhove T, Calster BV, Gorp TV, Moerman P, Verbist G, Vergote I, Amant F. Vandenput I, et al. Int J Gynecol Cancer. 2010 Apr;20(3):363-7. doi: 10.1111/IGC.0b013e3181d4a0b9. Int J Gynecol Cancer. 2010. PMID: 20375798

9

Ineffective attempt to preserve fertility with a levonorgestrel-releasing intrauterine device in a young woman with endometrioid endometrial carcinoma: a case report and review of the literature.

Vandenput I, Van Eygen K, Moerman P, Vergote I, Amant F. Vandenput I, et al. Eur J Gynaecol Oncol. 2009;30(3):313-6. Eur J Gynaecol Oncol. 2009. PMID: 19697629 Review.

10

High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.

Garcia-Dios DA, Lambrechts D, Coenegrachts L, Vandenput I, Capoen A, Webb PM, Ferguson K; ANECS, Akslen LA, Claes B, Vergote I, Moerman P, Van Robays J, Marcickiewicz J, Salvesen HB, Spurdle AB, Amant F. Garcia-Dios DA, et al. Among authors: vandenput i. Gynecol Oncol. 2013 Feb;128(2):327-34. doi: 10.1016/j.ygyno.2012.11.037. Epub 2012 Dec 4. Gynecol Oncol. 2013. PMID: 23219661

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results